(Q46245952)

20 December 2017

title

Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis (English)

1 reference

20 December 2017

author name string

Guoqing Hou

1

1 reference

20 December 2017

Gerald D Abrams

2

1 reference

20 December 2017

Robert Dick

3

1 reference

20 December 2017

George J Brewer

4

1 reference

20 December 2017

publication date

11 October 2008

1 reference

20 December 2017

published in

Translational Research

1 reference

20 December 2017

volume

152

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

239-244

1 reference

20 December 2017

Initial therapy of patients with Wilson's disease with tetrathiomolybdate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Determination of serum creatinine by a direct colorimetric method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

A rush to judgment on Th17

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.09.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2008.09.003

1 reference

20 December 2017

1 reference

20 December 2017